Unique Clinical Pearl sessions are held throughout the AAPP Annual Meeting. Slide sets for these sessions are made available through the AAPP Communities.
2023 Annual Meeting
- Adams K. Clozapine-Induced Gastrointestinal Hypomotility. [Weblink]
- Ferren J. Autoimmune Encephalitis: What Psychiatric Pharmacists Should Know. [Weblink]
- Liveoak K. Xylazine: A New Deadly Threat to Public Health. [Weblink]
- Schwab S. Using Midazolam for Managing Acute Agitation. [Weblink]
- Stutzman D. Aripiprazole for Anorexia Nervosa. [Weblink]
- Thacker E. Beyond Benzos: Treatment of Refractory Catatonia. [Weblink]
2022 Annual Meeting
- Cusimano J. Parkinsonism-hyperpyrexia Syndrome. [Weblink]
- Doroudgar S. Antipsychotic-Induced Hyperprolactinemia: An Approach to Medication Management. [Weblink]
- Liriano C. Clozapine: Removing the Smoke Screen. [Weblink]
2021 Annual Meeting
- Cusimano J. Phenibut Withdrawal. [Weblink]
- Hahn N. Folic Acid Supplementation in Women with Epilepsy on Antiepileptic Drug(s). [Weblink]
- Shuman M. Morbid Obesity: Implications for the Psychiatric Patient (and Practitioner). [Weblink]
2020 Annual Meeting
- Barlow G. Acute Pain Management and Buprenorphine: A Paradigm Shift. [Weblink]
- Brockbank J. Pre-Exposure Prophylaxis for HIV: A Primer for Psychiatric Pharmacists. [Weblink]
- Davis E. Haloperidol as Non-opioid Alternative for Chronic Abdominal Pain/Headache in the Emergency Department. [Weblink]
- Ehret M. Development of an Esketamine Administration Clinic. [Weblink]
- Hampton C. The Cannabis Analysis: Discussing Common Contaminants in Cannabidiol-Related Products. [Weblink]
- Pals H. Unexpected Consequences of Medication Misuse: Robotripping into Bromism. [Weblink]
Reviewer 1: Joseph M. Cusimano, PharmD, BCPP
Reviewer 2: Austin Smith, PharmD, BCPP
2023-2024 AAPP Resident and New Practitioner Committee
